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Abstract
Objectives:  To evaluate the success of shock wave lithotripsy (SWL) as monotherapy for solitary renal
stones larger than 2 cm without ureteral stenting. Hence, if our study result demonstrates acceptable success
and safety, we can recommend ESWL as a treatment option for patients with large renal calculi.
Subjects and  methods:  This is a prospective study conducted in the Department of Urology, Regional Insti-
tute of Medical Sciences, Imphal, India, from January 2011 to December 2012. A total of 104 patients
aged between 20 and 70 years with solitary large (>2 cm) renal stones underwent ESWL using the Dornier
Compact Sigma Lithotripter. Stone size was calculated by measuring the largest dimension of the stone
in KUB plain films. In each session, 3000–3500 shocks at frequency 60–90 min−1 and intensity between
1 and 4 were given. A maximum number of six sessions were given. Successful treatment was defined as
complete clearance or residual stones smaller than 4 mm on KUB performed 3 months after the first session.
Results:  Total number of patients was 104. The M:F ratio was 1:1.4. The stone size ranged from 21 to
55 mm. The overall success rate was 73%. For stones >30 mm, the success rate was only 62.2% (n  = 28).
The number of sessions required increased as the stone size increased. The most common complication
encountered was haematuria.∗ Corresponding author at: Department of Urology, RIMS, Imphal,
Manipur 795004, India. Tel.: +91 7308940144.
E-mail address: drsandeepgupta2009@yahoo.in (S. Gupta).
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Conclusion:  ESWL remains the cornerstone of therapy for renal calculi less than 2 cm. Our study reveals
that multiple sessions were required for solitary renal calculi, with higher rate of ancillary procedures.
The success rate of ESWL for both non-staghorn and staghorn calculi with size above 2 cm is low, so
other treatment modalities like PCNL should be considered as the first treatment option. However, with
appropriate patient selection, significant improvements in stone-free rates may be achieved.
© 2013 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. 
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rinary stone disease is one of the mankind’s most ancient ailments,
urrently remaining a common cause for both office and emergency
oom referrals. The goal of renal stone management is to achieve
aximal stone clearance with minimal morbidity to the patient.
ultiple options are currently available. The introduction of extra-
orporeal shock wave lithotripsy (ESWL) for the treatment of renal
tones by Chaussy et al. in 1980 has been a very significant mile-
tone [1]. ESWL has revolutionized the treatment of kidney stone
isease and the majority of “simple” renal calculi (about 80–85%)
an be treated satisfactorily with ESWL [2]. Multiple studies have
eaffirmed the relation of stone free rates with stone size, stone loca-
ion and stone number [3,4]. ESWL has traditionally constituted the
avoured approach for small to moderate sized intrarenal calculi. In
ontrast, PCNL, although more invasive and often associated with
igher morbidity, achieves better stone-free rates and is not affected
y stone size [2]. For stones >20 mm in largest dimension, percu-
aneous nephrolithotomy (PCNL) is the first-line treatment. This is
ue to the higher retreatment rates and lower likelihood of achieving
tone-free state with ESWL in comparison of PCNL [5]. The AUA
ephrolithiasis Clinical Guidelines Panel on Staghorn Calculi con-
luded that ESWL monotherapy is not recommended as a first-line
reatment for large renal calculi and that it should only be used in
ombination with PCNL, whereas the PCNL being performed after
SWL [6].
his study was aimed to assess the success rate of ESWL as
onotherapy for larger renal stones and the safety of this therapy
ithout prophylactic DJ stenting. We studied the outcome of ESWL
onotherapy in patients with solitary renal stones greater than 2 cm
ho opted for it after knowing the various options of treatment.
ubjects  and  methods
his study is a prospective study conducted in the Department of
rology, Regional Institute of Medical Sciences, Imphal, India,
rom January 2011 to December 2012.
atients aged between 20 and 70 years with nephrolithiasis with
olitary radio-opaque large (>2 cm) renal stones were included in
he study. The treatment was carried out using “Dornier Compact
igma Lithotripter (Dornier Medtech, Germany)”, a third generation
lectromagnetic lithotripter with an integrated Ultrasound for stone
ocalization and monitoring.thical clearance was taken from the ethics committee of our insti-
ute prior to the commencement of the study. All the patients
ere informed about the other available options (like pyelolitho-
omy, PCNL) available in our institute to deal with these kinds
A
f
df stones. In this part of the country, the patients prefer a non-
nvasive mode of treatment initially. Hence, we even have 6 cases of
ower calyceal stones in our study. All the patients were explained
bout the procedure and the possibility that their treatment may be
nsuccessful and we might have to resort to other modes of treat-
ent to clear their stones. Informed written consent was taken from
ll the patients. Patients with congenital anomalies of the kidney,
atients with a percutaneous nephrostomy and patients having a
istory of previous renal surgery on the affected side were excluded
rom the study. Also excluded were patients with bilateral calculi,
ross hydronephrosis, those having features of obstruction, patients
ith solitary kidney and patients with deranged renal function.
he variables studied were age, sex and the location and size of
he renal calculi. Pre-treatment KUB plain films, ultrasonography
nd intravenous urography were performed in all patients. Rou-
ine investigations included a complete hemogram, bleeding time
BT), coagulation time (CT), electrocardiogram (ECG), urine R/E
nd C/S, kidney function test (KFT), random blood sugar level. For
atients with lower calyceal stones, only those patients having an
btuse infundibulo-pelvic angle, wide and short infundibular length
ere included in the study. Stone composition was not evaluated in
he present study.
tone size was calculated by measuring the largest dimension of the
tone in KUB (kidney, ureter and bladder) plain films. Patient prepa-
ation included liquid diet after bowel preparation with 2 tablets
ulcolax and 4 tablets charcoal previous night after dinner and
atients were given analgesic medication in the form of Diclofenac
5 mg intramuscular injection just before starting the session. All
ere treated in supine position with number of shocks per session
anging between 3000 and 3500 at the frequency of 60–90 min−1
nd intensity between 1 and 4 depending on the tolerance level of
he individual. Proper antibiotics, analgesics and haemostatics were
rescribed post procedure. All patients were instructed to report
ven the minor complications after treatment and were kept under a
lose follow-up. One week after the treatment, X-ray or ultrasound
as used to check the existence of haematoma or the evolution of the
ithiasis. If the residual fragment size was more than 4 mm a repeat
ession was advised, otherwise patients were discharged from the
reatment regimen. A maximum number of six sessions were given
fter which it was labelled unsuccessful. We did not contemplate
oing repeat serum creatinine during the study period as we did
ot do any case with bilateral stones, deranged renal function, etc.,
hich could have raised the creatinine during the ESWL sessions.
uccessful treatment was defined as complete clearance or residual
tones 4 mm on KUB performed 3 months after the first session.ll statistical analyses were performed using Statistical Package
or the Social Sciences (SPSS 16.0) for windows. All categorical
ata were presented using frequencies and percentage. Associations
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Table  1  Patient and stone characteristics.
Number of patients 104
Male:female  1:1.4
Male 44 (42.3%)
Female 60 (57.7%)
Age  group 20–70 years (mean = 39.4 years)
Stone location
Upper calyx 03 (2.9%)
Middle calyx 02 (1.9%)
Lower calyx 06 (5.8%)
Pelvis 72 (69.2%)
Pelvicalyx 21 (20.2%)
Laterality
Right 58 (55.8%)
Left 46 (44.2%)
Table  2  Size and laterality of the stones.
Stone size (mm) Total number of cases Total no. of
cases (%)
Right kidney Left kidney
21–30 33 26 59 (56.7)
31–40 14 12 26 (25)
41–50 09 07 16 (15.4)
51–55 02 01 03 (2.9)
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between categorical variables were assessed using Chi-square test
with Yates’ correction and ANOVA test. A P  value less than 0.05
was considered statistically significant.
Results
During this study period, a total number of 353 patients underwent
ESWL for either renal or ureteral calculi. Out of this, 104 were those
patients who were enrolled in our study, i.e. those who underwent
ESWL for solitary large renal stones. No patient left the study in
between. The male:female ratio was 1:1.4 (M = 44, F = 60).
The mean age of the patients was 39.4 years. More than 70% of the
patients were in the age group of 30–60 years. Table 1 shows the
distribution of each category of cases among these 104 patients.
The stone size ranged from 21 to 55 mm. Of all the 104 cases, 58
had involvement of the right kidney (55.8%) while the remaining
46 cases had calculus in the left kidney (44.2%). The maximum
number of calculi ranged between 21 and 30 mm (56.7%).
Table 2 shows the number of cases as per the different sizes of the
renal calculi in the present study as well as their laterality.
The mean number of ESWL sessions required to break the stones
varied with the size as well as the location of the renal calculi.
For stones located in the upper calyx, the mean number of sessions
received was 2, in the middle calyx was 3.2, in the lower calyx was
3.9, in the pelvis was 3.22 and in the pelvicalyx was 3.93. All of
our patients could tolerate the procedure with a single intramuscular
injection of Diclofenac 75 mg before each session. However, there
e
s
f
t
Table  3  Success of ESWL as monotherapy in large renal calculi.
Stone size (mm) No. of cases Number of
sessions
(mean ± SD)
Stone 
clinica
fragm
21–30 59 3.28 ± 1.98 48 
31–40 26 3.58 ± 1.94 17 
41–50 16 4.83 ± 3.05 09 
51–55 03 3.66 ± 2.77 02 ere some patients who complained of pain during the procedure.
n such cases, we stopped the procedure for some time, or decreased
he frequency/intensity. None of the patients required any other form
f anaesthesia.
he results of our study are shown in Table 3. The success rate is
epicted based on the imaging findings at 3 months.
he overall success rate was 73%. But if we consider those cases
ith stone size >30 mm, the success rate is only 62.2% (n  = 28).
here were 5 (4.8%) cases in which, even after three sessions,
here was minimal to nil stone fragmentation. Hence, such cases
ere not subjected to further ESWL. Overall, the failure rate was
6.9% (n  = 28). The failure cases underwent surgical procedure
or stone retrieval. Two of the failure patients underwent PCNL
hile the remaining 26 patients underwent open pyelolithotomy for
tone clearance. We did not perform more of PCNL as is has been
ecently introduced in our centre and we are still in the learning
urve. The mean number of sessions increased as the stone size
ncreased while the success rate decreased with increasing stone
ize. Among the complications encountered, the most common was
hat of haematuria (38%) followed by steinstrasse (18.3%). The
omplications encountered are presented below in Table 4. Haema-
uria was transient, mild and subsided within 2–3 days with the help
f oral tranexamic acid thrice a day for 3 days and adequate bed rest
nd fluid intake. It was found to be more in cases who underwent
SWL at a higher intensity. The incidence of steinstrasse was high-
st in the group with stone size >4 cm (26.3%). Eight (42%) of the
atients were symptomatic, having features like flank pain, fever
nd nausea. The remaining cases were diagnosed incidentally on
he follow-up X-ray KUB. All of the patients were initially treated
y conservative management using adequate hydration, tamsulosin
0.4 mg HS) and analgesic on demand for a maximum of 2 weeks. If
ven after this period there was minimal or no stone clearance, they
ere taken up for URSL (ureteroscopic lithotripsy) using pneumatic
nergy. Twelve (63.2%) of the steinstrasse cases were managed con-
ervatively whereas the remaining seven (36.8%) underwent URSL
or clearance. None of the patients had to under open ureterolitho-
omy. Two (1.92%) patients developed perirenal haematoma after
free patients (including
lly insignificant
ents)
Non stone free
patients
Overall success
rate (%)
11 81.3
09 65.4
07 56.2
01 66.7
182 
Table  4  Complications of ESWL in the present study.
Complication Total no. of cases (%)
1. Haematuria 39 (38)
2. Steinstrasse 19 (18.3)
(a) Stone size
21–30 mm 10/59 (16.9)
31–40 mm 04/26 (15.4)
41–55 mm 05/19 (26.3)
(b) Presentation
Symptomatic 08/19 (42)
Incidental 11/19 (58)
(c)  Management
Conservative 12/19 (63.2)
URSL 07/19 (36.8)
3.  Skin bruise 21 (20)
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l4. Perirenal haematoma 02 (1.92)
he fourth session which subsided in a period of 3 months with
onservative management.
iscussion
hile extracorporeal shock wave lithotripsy (SWL) is considered
 highly effective treatment for upper urinary tract stones, con-
erns about the efficacy of SWL have dampened enthusiasm for
he treatment [7,8]. These concerns have been heightened by the
act that second generation and more recent lithotripters appear less
ffective at breaking stones [9–11]. Till date, the unmodified HM-3
ithotripter (Dornier Medtech Europe GmbH, Wessling, Germany)
s considered the most effective lithotripter in terms of success rates,
aving showed high stone-free rates (SFRs) that have not been
atched with later-generation lithotripters and it is the reference
tandard against which the outcome of treatment on other machines
s compared. Also, as the stone size increases there is a signifi-
ant reduction in stone-free rates for single renal calculi treated
ith ESWL monotherapy with reported mean stone-free rates of
9.9% (range 63–90%), 64.1% (range 50–82.7%), and 53.7% (range
3.3–81.4%) for stones less than 10 mm, 11–20 mm, and larger than
0 mm, respectively [12–14].
n the 1980s, ESWL monotherapy was applied for stones >2 cm;
owever, the need for multiple treatments, the high incidence of
djunctive procedures required and the low stone-free rate prompted
he recommendation that large calculi should be treated with combi-
ation therapy (PCNL + ESWL)[15]. In their first report of clinical
ata on ESWL, Chaussy et al., reported a SFR of ≈90% [16]. In the
andmark US cooperative study of ESWL, Drach et al. reported a
FR of 77.4% with the HM-3 at 3 months after treatment [17].
ccording to NIH consensus conferences recommendation, patients
ith stones larger than 2 cm, should be approached with PNL ini-
ially, followed if needed by ESWL due to high retreatment rates
nd the need for ancillary procedures [18]. However, many of the
entres across the globe treat these patients with ESWL monother-
py with good success rates [19]. A decade ago, the results of
SWL monotherapy for solitary renal stones >2 cm were variable
nd stone-free rate was varying from 33% to 65% [20]. The advance-
ent of technology and current expertise in ESWL has yielded much
igher stone-free rates [19]. In our study, 104 patients with solitary
a
r
s
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arge renal stones above 2 cm in size underwent ESWL with electro-
agnetic Dornier compact Sigma Lithotripter without DJ stenting.
hen we consider the outcome of ESWL in stone size of 2–3 cm,
he success rate was around 82%, which is at par with the 90%
uccess rate of PCNL [5].
be et al. reported 46% stone clearance and 54% residual fragments
mong 267 patients with renal stones with size between 20 and
0 mm in their series of 3024 patients treated with ESWL monother-
py. All patients had DJ stenting prior to ESWL monotherapy. Their
verall stone-free rate was 65.1%, and the success rate was 85.7%
hen they analyzed all the patients with stone size varying between
 and 30 mm [21]. In another such study, Psihramis et al. reported
n 94 renal stones larger than 2 cm treated with ESWL, the success
ate was only 33%. Patients with multiple stones had a similar stone-
ree rate of 32% [22]. As observed in this study, success rate was not
ignificantly different with respective of stone location. This may be
ecause the cases are not equally distributed according to location.
he number of cases seen in upper, middle and lower calyces is
uite low.
SWL is not complication-free despite its relatively non-invasive
ature. The estimated rate of overall complications reported for
SWL therapy for staghorn calculi ranged from 13% to 19% [6]. The
ost common complication encountered in our study was haema-
uria, which was mostly mild and transient, and which was reported
n 38% of the patients. Another common complication was that of
teinstrasse which was seen in 18.3% of our cases (n  = 19). Inter-
stingly, its incidence was more common in patients with stone size
30 mm. Goyal et al. [23], observed a 11.1% incidence of stein-
trasse following ESWL for stones between 2 and 3 cm and 18.5%
n stones >3 cm. Kim et al. [24], observed a 0.3% incidence of ste-
nstrasse for stones <1 cm compared with 18.8% for stones >4 cm.
he role of pre-ESWL JJ stenting for large renal stones still remains
 topic of discussion. Libby et al. found that pre-treatment place-
ent of DJ stents reduced the requirement of auxiliary procedures
rom 15% to 6% and complications from 26% to 7% [25]. Shouman
t al. stated that DJ stenting is not required for a successful ESWL
or even larger stone burden [19]. Kumar et al. [26] have shown that
WL monotherapy for renal stones without stenting is safe even
n solitary kidneys. Despite the inter-observer variations regarding
re-ESWL stenting, before ESWL monotherapy, our study showed
hat pretreatment stenting, it can safely be stated that closer follow-
p is required in all the cases to ensure successful and uninterrupted
assage of the stone fragments.
onclusion
hock wave lithotripsy is non-invasive and requires the least anaes-
hesia among the treatment modalities and therein lays its popularity.
n the last decade, however, there have been changes in thinking
egarding the methods of patient selection for shock wave lithotripsy,
hanges in the technique of the existing shock wave lithotripters, and
ew technologies designed to increase the efficacy of shock wave
ithotripters especially for “complex” patients. In our study of ESWL
or large solitary renal calculi above 2 cm in size, the patients with
arge renal calculi required multiple ESWL sessions and the rate of
ncillary procedures are high. The success rate of ESWL in large
enal calculi above 2 cm in size is low, so for both non-staghorn and
taghorn calculi with size above 2 cm, other treatment modalities
ike PCNL should be considered as the first treatment option. But in
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patients who are not fit for invasive surgeries like PCNL and open
surgery or those reluctant to undergo an invasive procedure, ESWL
can be considered as a viable, alternative treatment option. For stone
size between 2 and 3 cm, especially those in the renal pelvis or pelvi-
calyx, ESWL can be considered as the first treatment option. With
appropriate patient selection, based on a comprehensive evaluation
of stone related factors (size, number, location, and composition),
renal anatomy, and patient clinical factors, significant improvements
in stone-free rates may be achieved.
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